Contrast-associated acute kidney injury (AKI) is a common iatrogenic complication
associated with increased health resource utilization and adverse outcomes, including short …

Acute kidney injury (AKI) is a well-recognized iatrogenic sequela of intravascular iodinated
contrast media administration. The incidence of contrast-associated acute kidney injury (CA …

Contrast-induced acute kidney injury (AKI) is an important complication following the use of
iodinated contrast media, accounts for a significant number of cases of hospitalacquired AKI …

Contrast-induced acute kidney injury (AKI)(also known as contrast-induced nephropathy) is
an abrupt deterioration in renal function that can be associated with use of iodinated contrast …

Contrast‐induced AKI (CI‐AKI) has been one of the leading causes for hospital‐acquired
AKI and is associated with independent risk for adverse clinical outcomes including …

Contrast-induced acute kidney injury (CIAKI) occurs in up to 30% of patients who receive
iodinated contrast media and is generally considered to be the third most common cause of …

As lifespans lengthen, age-related diseases such as cardiovascular disease and diabetes
are becoming more prevalent. Correspondingly, the use of contrast agents for medical …

Over 70 million computed tomography (CT) scans are performed yearly in the United States,
1 approximately half of which use iodinated radiocontrast media, and over 2 million patients …

For decades, when contrast agents are administrated, physicians have been concerned
because of the risk of inducing acute kidney injury (AKI). Recent literature questions the …

The intravascular administration of iodine-based contrast media remains a common cause
of acute kidney injury and a leading cause of iatrogenic renal disease. Past research has …